slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 60,391-60,420
Pages 2,605
Rows per page 30
Component
60,391-60,420 of 78,138
28
The slide highlights both historical performance (25+ years) and current operational reach.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · Growth StrategyLoop · Quick Win Big Bet1 hit
29
The chart shows a progression from baseline to net savings, including revenue increases, cost reductions, and shared savings.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · Growth StrategyLoop · Quick Win Big Bet1 hit
33
The chart uses a waterfall structure to explain the path from PMPM revenue to EBITDA.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations 1 hit
09
The chart uses a waterfall bridge to explain the 180bps decline.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations 1 hit
11
The chart highlights significant outflows in working capital, tech, and supply chain investments.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations 1 hit
13
The slide uses a bar chart to demonstrate a 20% CAGR and pairs it with three brand identity pillars.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations Beat · Key Messages1 hit
12
Includes clinical trial data visualization and product summary table.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
13
The slide uses a dark sidebar for product specs and a white main area for clinical data visualization.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
16
The chart uses a dot plot to show individual patient CADSS scores over time across three cohorts (30mg, 60mg, Placebo).ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
22
Includes a quote from Keith Nuechterlein and a detailed clinical trial timeline.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
28
Includes a sidebar summary and a clinical trial design overview.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
31
Uses a combination of a map, metric callouts, and a vertical process-style list to convey urgency.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
32
Includes a summary table on the left and clinical trial data/roadmap on the right.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
06
The slide uses a Gantt-style visualization to represent clinical trial progress for various drug candidates.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · AgitationLoop · Cost Of Inaction1 hit
15
CADSS = Clinician administered dissociative states scale. Data points are clustered by time interval.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
20
The chart compares 25mg, 10mg, and 1mg (comparator) dosages. Statistical significance is marked with asterisks.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
25
The chart displays statistical significance markers (p-values) at Day 1, Day 2, and Day 7.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
28
The chart shows a non-inferiority test using the Hamilton Anxiety Rating Scale (Ham-A).ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
30
Slide 30. Includes statistical significance markers (*, **, ***).ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
35
The slide uses a grouped bar chart to show T-scores across three cognitive tests (HVLT, Symbol Coding, Category Fluency) for four dosage groups.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
05
The chart shows a significant p-value of 0.018 for NfL reduction. The study design is noted as randomized, double-blind, placebo-controlled, and parallel-group.Athira Pharma | Results Presentation Deck | 11 slides · Athira Pharma
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
18
The chart shows BAER-101 regimens consistently resulting in lower sleepiness rates than Lorazepam.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank 1 hit
08
The chart shows the bridge from 10.5% to 11.0% CET1 ratio, detailing impacts from net income, dividends, repurchases, OCI, and RWA changes.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
04
The slide combines corporate facts with team and board composition.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations Beat · Team1 hit
11
The chart segments companies by the number of commercialized products and compares their IND filing rates (2015-2020) against BenevolentAI's projected targets.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
13
The chart uses a horizontal bar format to represent progress through clinical phases. Several programs are marked with AstraZeneca partnership dates.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
14
The slide uses a split-layout with a dark sidebar for partnership specifics and a light main area for strategic benefits.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
20
Includes explicit caveats regarding the small sample size and short duration of the Phase Ib study.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
22
The slide uses a process diagram to explain the experimental setup (biopsy -> organ culture -> measurement) followed by bar charts showing efficacy.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
32
The chart displays data from Bergamaschi et al. (2011) regarding acute CBD treatment for Social Anxiety Disorder (SAD).Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit